On July 12, the Minister of Health, Mrs. Ruxanda Glavan, met with AmCham Healthcare Committee to discuss the draft Regulation on drugs’ prices. Among the issues raised by AmCham representatives were the need to change the price formation rules for innovative and generic medicines, to amend the list of reference countries, as well as to maintain an effective mechanism of price adjustment for currency fluctuations. As a result, in the following days, the Ministry of Health will make available a new version of the Regulation.
Members Spotlight
Current number of members 181
